ABBV vs MRK
ABBV and MRK side by side — valuation & fundamentals (public data).
Key statistics
| Metric | ABBVAbbVie Inc. | MRKMerck & Co., Inc. |
|---|---|---|
| Market cap | $459.89B | $371.57B |
| P/E (TTM) | 73.5 | 120.5 |
| P/B | — | 8.86 |
| P/S | 7.4x | 5.6x |
| Dividend yield | 2.53% | 2.20% |
| Revenue | $61.16B(TTM) | $66.57B(TTM) |
| Revenue growth (YoY) | 8.6% | 1.3% |
| Net income | $6.31B(TTM) | $3.17B(TTM) |
| Earnings growth (YoY) | -1.2% | 6.6% |
| EPS, diluted | $3.54(TTM) | $1.25(TTM) |
| EBIT margin | 24.6% | 34.2% |
| ROE | — | 43.5% |
| ROIC | 18.6% | 21.6% |
| 1y total return | +25.1% | +76.8% |
Figures from SEC filings · for reference only · not investment advice
Growth of $10,000: ABBV vs MRK
| Metric | ABBV | MRK |
|---|---|---|
| End value | $64.9K | $37.7K |
| Total return | +549.5% | +276.5% |
| CAGR | +19.8% | +13.7% |
| Volatility | 25.9% | 23.3% |
| Sharpe | 0.68 | 0.50 |
| Sortino | 0.95 | 0.74 |
| Max drawdown | -45.1% | -43.4% |
Based on 2600 common trading days, 2016-04-29 → 2026-09-01 · risk-free 3.91% (current short-Treasury, held constant)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
Related comparisons
Delayed data · Public sources · For reference only · Not investment advice (this page declares no winner)